Chemotherapeutic Development Strategies for Schistosomiasis

Antiparasitic and Antibacterial Drug Discovery: From Molecular Targets to Drug Candidates

Volumn , Issue , 2009, Pages 299-321

  Caffrey, Conor R ^a   Williams, David L ^b   Todd, Matthew H ^c   Nelson, David L ^d   Keiser, Jennifer ^e   Utzinger, Jürg ^e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ILLINOIS STATE UNIVERSITY   (United States)

^c UNIVERSITY OF SYDNEY   (Australia)

^d FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^e SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

Author keywords

Antiparasitic; Chemotherapeutic development; Drug discovery; Multicellular parasites; Schistosomiasis

Indexed keywords

EID: 80053452934     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527626816.ch16     Document Type: Chapter

References (81)

1. Caffrey, C.R. and Steverding, D. (2008) Recent initiatives and strategies to developing new drugs for tropical parasitic diseases. Expert Opinion in Drug Discovery, 3, 173-186.
2. Hotez, P.J., Molyneux, D.H., Fenwick, A., Kumaresan, J., Ehrlich Sachs, S., Sachs, J.D. and Savioli, L. (2007) Control of neglected tropical diseases. New England Journal of Medicine, 357, 1018-1027.
3. Ridley, R.G. (2003) Product R&D for neglected diseases. Twenty-seven years of WHO/TDR experiences with public-private partnerships. EMBO Reports, 4 Spec No, S43-S46.
4. Moran, M. (2005) A breakthrough in R&D for neglected diseases: new ways to get the drugs we need. PLoS Medicine, 2, e302.
5. Nwaka, S. and Hudson, A. (2006) Innovative lead discovery strategies for tropical diseases. Nature Reviews Drug Discovery, 5, 941-955.
6. Widdus, R. (2005) Public-private partnerships: an overview. Transactions of the Royal Society of Tropical Medicine and Hygiene, 99 (Suppl. 1), S1-S8.
7. Steinmann, P., Keiser, J., Bos, R., Tanner, M. and Utzinger, J. (2006) Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk. Lancet Infectious Diseases, 6, 411-425.
8. King, C.H. and Dangerfield-Cha, M. (2008) The unacknowledged impact of chronic schistosomiasis. Chronic Illness, 4, 65-79.
9. Caffrey, C.R. (2007) Chemotherapy of schistosomiasis: present and future. Current Opinion in Chemical Biology, 11, 433-439.
10. Fallon, P.G. and Doenhoff, M.J. (1994) Drug-resistant schistosomiasis: resistance to praziquantel and oxamniquine induced in Schistosoma mansoni in mice is drug specific. American Journal of Tropical Medicine and Hygiene, 51, 83-88.
11. Botros, S. and Bennett, J.L. (2007) Praziquantel resistance. Expert Opinion in Drug Discovery, 2, S35-S40.
12. Fenwick, A. and Webster, J.P. (2006) Schistosomiasis: challenges for control, treatment and drug resistance. Current Opinion in Infectious Diseases, 19, 577-582.
13. Lammie, P.J., Fenwick, A. and Utzinger, J. (2006) A blueprint for success: integration of neglected tropical disease control programmes. Trends in Parasitology, 22, 313-321.
14. Cioli, D. and Pica-Mattoccia, L. (2003) Praziquantel. Parasitology Research, 90 (Supp. 1), S3-S9.
15. Doenhoff, M.J. and Pica-Mattoccia, L. (2006) Praziquantel for the treatment of schistosomiasis: its use for control in areas with endemic disease and prospects for drug resistance. Expert Review of Anti-Infective Therapy 4, 199-210.
16. Seubert, J., Pohlke, R. and Loebich, F. (1977) Synthesis and properties of praziquantel, a novel broad spectrum anthelmintic with excellent activity against Schistosomes and Cestodes. Experientia, 33, 1036-1037.
17. Andrews, P., Thomas, H., Pohlke, R. and Seubert, J. (1983) Praziquantel. Medicinal Research Reviews, 3, 147-200.
18. Abo-Ghalia, M.H. and Soliman, A.E. (1996) Synthesis and antischistosomal activity of a new 2-nicotinoyl dipeptide analogue of praziquantel. Arzneimittelforschung, 46, 207-209.
19. Ronketti, F., Ramana, A.V., Xia, C.M., Pica-Mattoccia, L., Cioli, D. and Todd, M.H. (2007) Praziquantel derivatives I: Modification of the aromatic ring. Bioorganic & Medicinal Chemistry Letters, 17, 4154-4157.
20. Valls, N., Segarra, V.M. and Bosch, J. (1986) Praziquantel analogs. 1. New and short synthesis of 2-acyl-4-oxo-1, 2, 3, 4, 6, 7, 12, 12B-octahydropyrazino [1', 2'-1, 2]pyrido[3, 4-b]indoles. Heterocycles, 24, 943-946.
21. Valls, N., Segarra, V.M., López, X. and Bosch, J. (1989) Praziquantel analogues. II. Synthesis of 4-oxo-octahydro-pyrazino [1'2':1, 2]pyrido[3, 4-b]-and-[4, 3-b]indoles. Heterocycles, 29, 231-234.
22. Novaes, M.R.C.G., De Souza, J.P. and De Araújo, H.C. (1999) Sintese do anti-helmintico praziquantel, a partir da glicina. Quimica Nova, 22, 5-10.
23. Frehel, D. and Maffrand, J.-P. (1983) New synthesis of praziquantel: 2-(cyclohexylcarbonyl)-1, 2, 3, 6, 7, 11b-hexahydro-4H-pyrazino[2, 1-a]isoquinolin-4-one. Heterocycles, 20, 1731-1735.
24. Kim, J.H., Lee, Y.S. and Kim, C.S. (1998) Synthesis of praziquantel via N-acyliminium ion cyclization of amido acetals through several synthetic routes. Heterocycles, 48, 2279-2285.
25. Kim, J.H., Lee, Y.S., Park, H. and Kim, C.S. (1998) Formation of pyrazinoisoquinoline ring system by the tandem amidoalkylation and N-acyliminium ion cyclization: an efficient synthesis of praziquantel. Tetrahedron, 54, 7395-7400.
26. Yuste, F., Pallas, Y., Barrios, H., Ortiz, B. and Sánchez-Obregón, R. (1986) A short synthesis of praziquantel. Journal of Heterocyclic Chemistry, 23, 189-190.
27. Berkowitz, W.F. and John, T.V. (1984) An internal imino-Diels Alder route to a tetrahydroisoquinoline. Journal of Organic Chemistry, 49, 5269-5271.
28. Todd, M.H., Ndubaku, C.O. and Bartlett, P.A. (2002) Amino acid-derived heterocycles: Lewis acid-catalyzed and radical cyclizations from peptide acetals. Journal of Organic Chemistry, 67, 3985-3988.
29. Mansour, W., El-Fayoummy, S. and Todd, M.H. (2006) Solid phase synthesis of praziquantel. Tetrahedron Letters, 47, 1287-1290.
30. Kim, C.S. and Min, D.Y. (1998) Synthesis of praziquantel derivatives and their in vitro activity against adult Clonorchis sinensis. Archives of Pharmacal Research, 21, 744-748.
31. Manger, B.R. and Brewer, M.D. (1989) Epsiprantel, a new tapeworm remedy. Preliminary efficacy studies in dogs and cats. British Veterinary Journal, 145, 384-388.
32. Shekhter, O.V., Chernyak, A.S., Sergovskaya, N.L., Tsizin, Y. S., Mikhailitsyn, F.S., Drusvyatskaya, S.K. and Uvarova, N.A. (1990) Synthesis of tricyclic systems incorporating the azepine ring. Chemistry of Heterocyclic Compounds, 26, 1383-1387.
33. Ordorica, M.A., Velazquez, M.L., Ordorica, J.G., Escobar, J.L. and Lehmann, P.A. (1993) A principal component and cluster significance analysis of the antiparasitic potency of praziquantel and some analogues. Quantitative Structure-Activity Relationships, 12, 246-250.
34. Ma, C., Zhang, Q.F., Tan, Y.B. and Wang, L. (2004) Total synthesis of (-)-praziquantel: an anthelmintic drug. Journal of Chemical Research, 2004, 186-187.
35. Roszowski, P., Maurin, J.K. and Czarnocki, Z. (2006) Enantioselective synthesis of(R)-(-)-praziquantel (PZQ). Tetrahedron: Asymmetry, 17, 1415-1419.
36. Ching, C.B., Lim, G.G., Lee, E.J.D. and Ng, S.C. (1993) Preparative resolution of praziquantel enantiomers by simulated counter-current chromatography. Journal of Chromatography, 634, 215-219.
37. Wu, M.H., Wei, C.C., Xu, Z.Y., Yuan, H.C., Lian, W.N., Yang, Q.J., Chen, M., Jiang, Q.W., Wang, C.Z., Zhang, S.J., Liu, Z.D., Wei, R.M., Yuan, S.J., Hu, L.S. and Wu, Z.S. (1991) Comparison of the therapeutic efficacy and side effects ofa single dose of levo-praziquantel with mixed isomer praziquantel in 278 cases of schistosomiasis japonica. American Journal of Tropical Medicine and Hygiene, 45, 345-349.
38. Meyer, T., Sekljic, H., Fuchs, S., Bothe, H., Schollmeyer, D. and Miculka, C. (2009) Taste: a new incentive to switch to (R)-praziquantel in schistosomiasis treatment. PLoS: Neglected Tropical Diseases, 3, e357.
39. Klayman, D.L., Grenan, M.M. and Jacobus, D.P. (1969) Potential antiradiation agents. I. Primary aminoalkanethiosulfuric acids. Journal of Medicinal Chemistry, 12, 510-512.
40. Nelson, D.L. and Pellegrino, J. (1976) Experimental chemotherapy of schistosomiasis XII. Active derivatives of aminoethanethiosulfuric acids. Revista do Instituto de Medicina Tropical de Sao Paulo, 18, 365-370.
41. Pellegrino, J. and Faria, J. (1965) The oogram method for the screening ofdrugs in schistosomiasis mansoni. American Journal of Tropical Medicine and Hygiene, 14, 363-369.
42. Pellegrino, J. and Siqueira, A.F. (1956) A perfusion technic for recovery of Schistosoma mansoni from experimentally infected guinea pigs. Revista Brasileira de Malariologia e Doencas Tropicais, 8, 589-597.
43. Penido, M.L., Nelson, D.L., Vieira, L.Q. and Coelho, P.M. (1994) Schistosomicidal activity of alkylaminooctanethiosulfuric acids. Memorias do Instituto Oswaldo Cruz, 89, 595-602.
44. Penido, M.L., Nelson, D.L., Vieira, L.Q., Watson, D.G. and Kusel, J.R. (1995) Metabolism by Schistosoma mansoni of a new schistosomicide: 2-[(1-methylpropyl) amino]-1-octanethiosulphuric acid. Parasitology, 111, 177-185.
45. Katz, N. (1980) Experiencia com quimioterapia em grande escala no controle da esquistossomose no Brazil. Revista do Institute de Medicina Tropical de Sao Paulo, 22, 40-51.
46. Conceicao, M.J., Argento, C.A. and Correa, A. (2000) Study of Schistosoma mansoni isolates from patients with failure of treatment with oxamniquine. Memorias do Instituto Oswaldo Cruz, 95, 375-380.
47. Penido, M.L., Coelho, P.M. and Nelson, D.L. (1999) Efficacy of a new schistosomicidal agent 2-[(methylpropyl) amino]-1-octanethiosulfuric acid against an oxamniquine resistant Schistosoma mansoni isolate. Memorias do Instituto Oswaldo Cruz, 94, 811-813.
48. Moreira, L.S., Pilo-Veloso, D., de Mello, R.T., Coelho, P.M. and Nelson, D.L. (2007) A study of the activity of 2-(alkylamino)-1-phenyl-1-ethanethiosulfuric acids against infection by Schistosoma mansoni in a murine model. Transactions of the Royal Society of Tropical Medicine and Hygiene, 101, 385-390.
49. de Araujo, S.C., de Mattos, A.C., Teixeira, H.F., Coelho, P.M., Nelson, D.L. and de Oliveira, M.C. (2007) Improvement of in vitro efficacy of a novel schistosomicidal drug by incorporation into nanoemulsions. International Journal of Pharmaceutics, 337, 307-315.
50. Woolhouse, N.M. and Kaye, B. (1977) Uptake of [14C]oxamniquine by Schistosoma mansoni. Parasitology, 75, 111-118.
51. Klayman, D.L. (1985) Qinghaosu (artemisinin): an antimalarial drug from China. Science, 228, 1049-1055.
52. Li, Y. and Wu, Y.L. (2003) An over four millennium story behind qinghaosu (artemisinin)-a fantastic antimalarial drug from a traditional chinese herb. Current Medicinal Chemistry, 10, 2197-2230.
53. Bosman, A. and Mendis, K.N. (2007) A major transition in malaria treatment: the adoption and deployment of artemisininbased combination therapies. American Journal of Tropical Medicine and Hygiene, 77 (Suppl. 6), 193-197.
54. Utzinger, J., Xiao, S.H., Tanner, M. and Keiser, J. (2007) Artemisinins for schistosomiasis and beyond. Current Opinion in Investigational Drugs, 8, 105-116.
55. Utzinger, J., Keiser, J., Xiao, S.H., Tanner, M. and Singer, B.H. (2003) Combination chemotherapy of schistosomiasis in laboratory studies and clinical trials. Antimicrobial Agents and Chemotherapy, 47, 1487-1495.
56. Utzinger, J., Chollet, J., You, J.Q., Mei, J.Y., Tanner, M. and Xiao, S.H. (2001) Effect of combined treatment with praziquantel and artemether on Schistosoma japonicum and Schistosoma mansoni in experimentally infected animals. Acta Tropica, 80, 9-18.
57. Keiser, J. Utzinger, J. (2007) Advances in the discovery and development of trematocidal drugs. Expert Opinion in Drug Discovery, 2, S9-S23.
58. Vennerstrom, J.L., Arbe-Barnes, S., Brun, R., Charman, S.A., Chiu, F.C., Chollet, J., Dong, Y., Dorn, A., Hunziker, D., Matile, H., McIntosh, K., Padmanilayam, M., Santo Tomas, J., Scheurer, C., Scorneaux, B., Tang, Y., Urwyler, H., Wittlin, S. and Charman, W.N. (2004) Identification of an antimalarial synthetic trioxolane drug development candidate. Nature, 430, 900-904.
59. Dong, Y., Chollet, J., Matile, H., Charman, S.A., Chiu, F.C.K., Charman, W.N., Scorneaux, B., Urwyler, H., Santo Tomas, J., Scheurer, C., Snyder, C., Dorn, A., Wang, X., Karle, J.M., Tang, Y., Wittlin, S., Brun, R. and Vennerstrom, J.L. (2005) Spiro and dispiro-1, 2, 4-trioxolanes as antimalarial peroxides: charting a workable structure-activity relationship using simple prototypes. Journal of Medicinal Chemistry, 48, 4953-4961.
60. Xiao, S.H., Keiser, J., Chollet, J., Utzinger, J., Dong, Y., Endriss, Y., Vennerstrom, J.L. and Tanner, M. (2007) In vitro and in vivo activities of synthetic trioxolanes against major human schistosome species. Antimicrobial Agents and Chemotherapy, 51, 1440-1445.
61. Meshnick, S.R. (2002) Artemisinin: mechanisms of action, resistance and toxicity. International Journal for Parasitology, 32, 1655-1660.
62. Xiao, S.H., Chollet, J., Utzinger, J., Matile, H., Mei, J.Y. and Tanner, M. (2001) Artemether administered together with haemin damages schistosomes in vitro. Transactions of the Royal Society of Tropical Medicine and Hygiene, 95, 67-71.
63. Haas, B.J., Berriman, M., Hirai, H., Cerqueira, G.G., Loverde, P.T. and El-Sayed, N.M. (2007) Schistosoma mansoni genome: closing in on a final gene set. Experimental Parasitology, 117, 225-228.
64. Sayed, A.A., Cook, S.K. and Williams, D.L. (2006) Redox balance mechanisms in Schistosoma mansoni rely on peroxiredoxins and albumin and implicate peroxiredoxins as novel drug targets. The Journal of Biological Chemistry, 281, 17001-17010.
65. Sayed, A.A. and Williams, D.L. (2004) Biochemical characterization of 2-Cys peroxiredoxins from Schistosoma mansoni. Journal of Biological Chemistry, 279, 26159-26166.
66. Alger, H.M. and Williams, D.L. (2002) The disulfide redox system of Schistosoma mansoni and the importance of a multifunctional enzyme, thioredoxin glutathione reductase. Molecular and Biochemical Parasitology, 121, 129-139.
67. Kalinna, B.H. and Brindley, P.J. (2007) Manipulating the manipulators: advances in parasitic helminth transgenesis and RNAi. Trends in Parasitology, 23, 197-204.
68. Pereira, T.C., Pascoal, V.D., Marchesini, R.B., Maia, I.G., Magalháes, L.A., Zanotti-Magalhaes, E.M. and Lopes-Cendes, I., (2008) Schistosoma mansoni: evaluation of an RNAi-based treatment targeting HGPRTase gene. Experimental Parasitology, 118, 619-623.
69. Kuntz, A.N., Davioud-Charvet, E., Sayed, A.A., Califf, L.L., Dessolin, J., Arner, E.S. and Williams, D.L. (2007) Thioredoxin glutathione reductase from Schistosoma mansoni: an essential parasite enzyme and a key drug target. PLoS Medicine, 4, e206.
70. Gromer, S., Urig, S. and Becker, K. (2004) The thioredoxin system-from science to clinic. Medicinal Research Reviews, 24, 40-89.
71. Krauth-Siegel, R.L., Bauer, H. and Schirmer, R.H. (2005) Dithiol proteins as guardians of the intracellular redox milieu in parasites: old and new drug targets in trypanosomes and malaria-causing plasmodia. Angewandte Chemie (International Edition in English), 44, 690-715.
72. Austin, C.P., Brady, L.S., Insel, T.R. and Collins, F.S. (2004) NIH Molecular Libraries Initiative. Science, 306, 1138-1139.
73. Simeonov, A., Jadhav, A., Sayed, A.A., Wang, Y., Nelson, M.E., Thomas, C.J., Inglese, J., Williams, D.L. and Austin, C.P. (2008) Quantitative high-throughput screen identifies inhibitors of the Schistosoma mansoni redox cascade. PLoS: Neglected Tropical Diseases, 2, e127.
74. Sayed, A.A., Simeonov, A., Thomas, C.J., Inglese, J., Austin, C.P. and Williams, D.L. (2008) Identification ofoxadiazoles as new drug leads for the control of schistosomiasis. Nature Medicine, 14, 407-412.
75. Aguirre, G., Boiani, M., Cerecetto, H., Fernandez, M., Gonzalez, M., Leon, E., Pintos, C., Raymondo, S., Arredondo, C., Pacheco, J.P. and Basombrio, M.A. (2006) Furoxan derivatives as cytotoxic agents: preliminary in vivo antitumoral activity studies. Die Pharmazie, 61, 54-59.
76. Renslo, A.R. and McKerrow, J.H. (2006) Drug discovery and development for neglected parasitic diseases. Nature Chemical Biology, 2, 701-710.
77. Caffrey, C.R., McKerrow, J.H., Salter, J.P. and Sajid, M. (2004) Blood 'n' guts: an update on schistosome digestive peptidases. Trends in Parasitology, 20, 241-248.
78. Caffrey, C.R., Salter, J.P., Lucas, K.D., Khiem, D., Hsieh, I., Lim, K.C., Ruppel, A., McKerrow, J.H. and Sajid, M. (2002) SmCB2, a novel tegumental cathepsin B from adult Schistosoma mansoni. Molecular and Biochemical Parasitology, 121, 49-61.
79. Abdulla, M.H., Lim, K.C., Sajid, M., McKerrow, J.H. and Caffrey, C.R. (2007) Schistosomiasis mansoni: novel chemotherapy using a cysteine protease inhibitor. PLoS Medicine, 4, e14.
80. Ridley, R.G. and Kita, J. (2007) Helminth Drug Initiative. Expert Opinion in Drug Discovery, 2 (Suppl. 1), S1.
81. Kola, I. and Landis, J. (2004) Can the pharmaceutical industry reduce attrition rates? Nature Reviews Drug Discovery, 3, 711-715.